References
- Cady B, Stone M, McDermott W V. Technical and biological factors in disease-free survival after hepatic resection for colorectal cancer metastasis. Arch Surg 1992; 127: 561–9
- Nagao T, Goto S, Kawano N. Hepatic resection for hepatocellular carcinoma–clinical features and long-term prognosis. Ann Surg 1987; 205: 33–40
- Hughes K, Scheele J, Sugarbakcr P H. Surgery for colorectal cancer metastatic to the liver: optimizing the results of treatment. Surg Clin North Am 1989; 69: 339–59
- Adson M A. Resection of liver metastases; when is it worthwhile?. World J Surg 1987; 11: 511–20
- Stimpson R EJ, Pellegrini C A, Way L W. Factors affecting the morbidity of elective liver resection. Am J Surg 1987; 153: 189–96
- Bismuth H, Houssin D, Mazmanian G. Postoperative liver insufficiency: prevention and management. World J Surg 1983; 7: 505–10
- Almersjo O, Bengmark S, Hafström L O, Olsson R. Enzyme and function changes after extensive liver resection in man. Ann Surg 1969; 169: 111–9
- Aronsen K F, Ericsson B, Phil B. Metabolic changes following major hepatic resection. Ann Surg 1969; 169: 102–10
- McIntosh E L, Minuk G Y. Hepatic resection in patients with cirrhosis and hepatocellular carcinoma. Surg Gynecol Obstet 1992; 174: 245–54
- Yanaga K, Kanematsu T, Sugimachi K, Takenaka K. Intraperitoneal septic complications after hepatectomy. Ann Surg 1986; 203: 148
- Kormann M G, Holmann A F, Summerskill W HJ. Assessment of activity in chronic active liver disease. Serum bile acids compared with conventional tests and histology. N Engl J Med 1974; 290: 1399–402
- Neale G, Lewis B, Weaver V, Panveliwalla D. Serum bile acids in liver disease. Gut 1971; 12: 145–52
- Hirayama C, Irisa T, Arimura K, Nakamura M. Diagnostic significance of fasting scrum bile acids in liver disease. Acta Hepatogastroenterol 1976; 23: 385–91
- Couinaud C. Le foie–etudes anatomiques et chirurgicales. Masson, Paris 1957
- Chen M F, Hwang T S, Hung C F. Human liver regeneration after major hepatectomy–a study of liver volume by computed tomography. Ann Surg 1991; 213: 227–9
- Spiegel H U, Hauss J, Langhans P, Brown S, Brcilsch C E. Hypoxia and reoxygenisation after temporary occlusion of the liver hilus. Eur J Surg Res 1990; 22(Suppl)74
- Fausa O, Gjone E. Serum bile acid concentrations in patients with liver disease. Scand J Gastroenterol 1976; 11: 537–43
- Bismuth H, Castaing D, Garden O J. Major hepatic resection under vascular exclusion. Ann Surg 1982; 210: 13–9
- Huguet C, Nordlinger B, Bloch P, Conrad J. Tolerance of the liver to prolonged normothermic ischemia. Arch Surg 1978; 113: 363–71
- Hirayama C, Irisa C. Serum cholesterol and bile acids in primary hepatoma. Clin Chim Acta 1976; 71: 21–5
- Didolkar M S, Fitzpatrick L W, Elias E G. Risk factors before hepatectomy, hepatic function after hepatectomy and computed tomographic changes as indicators of mortality from hepatic failure. Surg Gynecol Obstet 1989; 169: 17–26
- Weinbren K, Billing B H. Hepatic clearance of bilirubin as an index of cellular function in the regenerating liver. Br J Exp Pathol 1956; 37: 199
- Nagasue N, Yukaya H, Ogawa Y, Kohno H, Nakamura T. Human liver regeneration after major hepatic resection. Ann Surg 1987; 206: 30–9
- Ekberg K, Tranberg K G, Anderson R, Jeppson B, Bengmark S. Major liver resection: perioperative course and management. Surgery 1986; 100: 1–7
- Sue B, Panis Y, Belgheti J, Fekete F. “Natural history” of hepatectomy. Br J Surg 1992; 79: 39–42
- Kemeny M M, Ganteaume L, Goldberg D A, Hogan M, Terz J J. Preoperative staging with axial tomography and biochemical laboratory tests in patients with hepatic metastasis. Ann Surg 1986; 203: 169–72
- Makuuchi M, Takayama T, Gunven P, Kosuge T, Yamazaki S, Hasegawa H. Restrictive versus liberal blood transfusion policy for hepatectomies in cirrhotic patients. World J Surg 1989; 13: 644–8
- Makuuchi M, Mori T, Gunven P, Yamazaki S, Hasegawa H. Safety of hemihepatic vascular occlusion during resection of the liver. Surg Gynecol Obstet 1987; 164: 155–8
- Heumann D M, Mills S A, McCall J, Hylemon P B, Pandak W M, Vlahcevic Z R. Conjugates of ursodeoxycholate protect against cholestasis and hepatocellular necrosis caused by more hydrophobic bile salts. In vivo studies in the rat. Gastroenterology 1991; 100: 203–11
- Heumann D M, Pandak M W, Hylemon P B, Vlahcevic Z R. Conjugates of UDCA protect against cytotoxicity of more hydrophobic bile salts: in vitro studies in rat hepatocytes and human erythrocytes. Hepatology 1991; 14: 920–6
- Pace R F, Blenkharn J I, Edwards W J, Orloff M, Blumgard L, Benjamin I S. Intra-abdominal sepsis after hepatic resection. Ann Surg 1989; 209: 302–6